A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss

NCT07663630 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)
Cachexia

Interventions

DRUG: ponsegromab
DRUG: placebo

Sponsor

Pfizer